VEEV — Veeva Systems Inc.

Veeva Systems (VEEV) Q4 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Q4 2026 total revenue: $836 million
• Q4 non-GAAP operating income: $366 million
• Full-year total revenue: $3.195 billion
• Full-year non-GAAP operating income: $1.434 billion
• Subscription revenue growth for FY 2027 projected at 13%, with normalized billings growth at 11%.

2. Strategic Updates and Business Highlights:

• Veeva achieved a significant milestone by surpassing the $3 billion revenue run rate goal in FY 2026.
• The company deepened strategic partnerships within the life sciences sector, focusing on modernization and automation of core systems.
• Veeva's CRM business is expected to decline from 20% of total revenue today to about 10% by 2030, with growth anticipated from new products like Campaign Manager and Service Center.
• The company is focusing on AI integration, particularly in commercial content and safety, with ongoing projects to enhance efficiency and effectiveness.

3. Forward Guidance and Outlook:

• Veeva expects continued healthy growth, particularly from the Crossix business, although it faces tougher year-over-year comparisons.
• The company has not provided quarterly guidance for normalized billings but expects seasonality to remain similar to previous years.
• Overall, Veeva anticipates a stable trajectory towards its 2030 goals, with a focus on product excellence and customer success.

4. Bad News, Challenges, or Points of Concern:

• The company acknowledged challenges in the EDC (Electronic Data Capture) market, noting a slowdown in growth and the difficulty of penetrating top 20 customers.
• There is caution regarding the macroeconomic environment, although some clarity has emerged in the pharmaceutical sector.
• The CRM business is maturing, and while the transition to Vault CRM is progressing, there are risks associated with customers potentially reverting to Salesforce or custom solutions.
• Competitive pressures remain strong, particularly from established players like Medidata.

5. Notable Q&A Insights:

• AI is seen as a tool for automation but not the sole driver of demand; customers are primarily focused on modernizing legacy systems.
• Veeva's reputation for reliability and quality is a key factor in customer trust, especially when considering AI solutions.
• The company is actively pursuing partnerships with CROs (Contract Research Organizations) to leverage their technology in clinical trials.
• There is a growing interest in Veeva's AI capabilities, particularly in safety and content management, although the market's adoption of AI in these areas is still developing.
• Veeva's leadership believes that AI will enhance their core systems rather than replace them, emphasizing the importance of integration and trust in their offerings.

Overall, Veeva closed FY 2026 on a strong note with solid financial results and strategic initiatives aimed at leveraging AI and modernizing its offerings, while also navigating challenges in a competitive landscape.